Loading
Latest filing published 10 Jun 2025 for X4 Pharmaceuticals, Inc. Read the official filing
No signal scores available.
Gary Bridger is a declared insider of X4 Pharmaceuticals, Inc, with filings sourced from SEC (Form 4). In total, 4 filings cover trades dated from 6 June 2022 to 9 June 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 10 June 2025: a share grant, in X4 Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations